|
 |
|
LETTER TO EDITOR |
|
|
|
|
| Year : 2011 | Volume
: 4
| Issue : 1 | Page : 59 |
| |
Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe
Pratibha Singh1, Manish Singh2, Goutham Cugati3, Ajai Kumar Singh4
1 Department of Obstetrics & Gynaecology, JIPMER, Puducherry, India
2 Department of Neurosurgery, JIPMER, Puducherry, India
3 Department of Neurosurgery, VHS Hospital, Taramani, Chennai, India
4 Department of Neurology, Dr. Ram Manohar Lohia Institute of Medical Sciences, Lucknow, Uttar Pradesh, India
| Date of Web Publication | 28-Jun-2011 |
Correspondence Address:
Manish Singh
Department of Neurosurgery, Jawaharlal Institute of Postgraduate Medical Education and Research, Dhanvantri Nagar, Puducherry - 605 006
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0974-1208.82367
How to cite this article:
Singh P, Singh M, Cugati G, Singh AK. Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe. J Hum Reprod Sci 2011;4:59 |
How to cite this URL:
Singh P, Singh M, Cugati G, Singh AK. Bromocriptine or cabergoline induced pituitary apoplexy: Rare but life-threatening catastrophe. J Hum Reprod Sci [serial online] 2011 [cited 2022 Jun 27];4:59. Available from: https://www.jhrsonline.org/text.asp?2011/4/1/59/82367 |
Sir,
Prolactin secreting pituitary tumor is one of the common causes of infertility in males and females. [1] Prolactin level is also high in non-prolactin secreting pituitary adenoma (e.g., growth hormone secreting) due to stalk effect. [2] Most of the prolactinomas can be managed medically with bromocriptine or cabergoline which are largely used as primary treatment for prolactinomas, as they help to normalize serum prolactin levels and induce reduction in the tumor size, promoting restoration of gonadal function, cessation of galactorrhea and improvement in visual defects in the majority of patients. [1],[2] Bromocriptine or cabergoline induced pituitary apoplexy is a life-threatening complication which is rare but well known. [2],[3],[4],[5] This condition is characterized by sudden onset of headache, visual loss or deterioration, meningismus, altered mental status, and rarely, even death. [1],[2] This pathology is caused by hemorrhagic necrosis of tumor or pituitary gland infarction, in which pituitary function is compromised, necessitating rapid administration of corticosteroids and endocrine evaluation. [1] Rapid surgical decompression is required if there is sudden constriction of visual fields, and/or rapid deterioration of acuity, or neurological deterioration due to hydrocephalus. [1],[2] These reports point toward the possibility of bromocriptine or cabergoline induced pituitary apoplexy, which should be kept in mind when a patient is neurologically deteriorating after starting these drugs. Careful follow-up is required when treatment with bromocriptine or cabergoline is attempted for prolactinoma in reproductive medicine clinic for infertility management in male and female patients.
 References | |  |
| 1. | Greenberg MS Handbook of neurosurgery: Pituitary adenomas. Sixth edition, Thieme Medical Publishers: New York; 2006. p. 438-56. 
|
| 2. | Knoepfelmacher M, Gomes MC, Melo ME, Mendonca BB. Pituitary Apoplexy During Therapy with Cabergoline in an Adolescent Male with Prolactin-Secreting Macroadenoma. Pituitary2004:7: 83-7.
|
| 3. | Shirataki K, Chihara K, Shibata Y, Tamaki N, Matsumoto S, Fujita T. Pituitary apoplexy manifested during a bromocriptine test in a patient with growth hormone and prolactin producing pituitary adenoma. Neurosurgery 1988;23:395-8.
[PUBMED] |
| 4. | Pinto G, Zerah M, Trivin C, Brauner R. Pituitary apoplexy in an adolescent with prolactin-secreting adenoma. Horm Res 1998;50:38-41.
[PUBMED] [FULLTEXT] |
| 5. | Yamaji T, Ishibashi M, Kosaka K, Fukushima T, Hori T, Manaka S, et al. Pituitary apoplexy in acromegaly during bromocriptine therapy. Acta Endocrinol(Copenh.) 1981;98:171-7.
|
| This article has been cited by | | 1 |
Evaluation of the Sellar and Parasellar Regions |
|
| Chin, B.M. and Orlandi, R.R. and Wiggins, R.H. | | Magnetic Resonance Imaging Clinics of North America. 2012; 20(3): 515-543 | | [Pubmed] | | | 2 |
Evaluation of the Sellar and Parasellar Regions |
|
| Brian M. Chin,Richard R. Orlandi,Richard H. Wiggins | | Magnetic Resonance Imaging Clinics of North America. 2012; 20(3): 515 | | [Pubmed] | [DOI] | |
|
|
|
|
